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Mapping protein–protein interactions is an invaluable tool for understanding protein function.
Here, we report the ﬁrst large-scale study of protein–protein interactions in human cells using a
mass spectrometry-based approach. The study maps protein interactions for 338 bait proteins that
were selected based on known or suspected disease and functional associations. Large-scale
immunoprecipitation of Flag-tagged versions of these proteins followed by LC-ESI-MS/MS analysis
resulted in the identiﬁcation of 24540 potential protein interactions. False positives and redundant
hits were ﬁltered out using empirical criteria and a calculated interaction conﬁdence score,
producing a data set of 6463 interactions between 2235 distinct proteins. This data set was further
cross-validated using previously published and predicted human protein interactions. In-depth
mining of the data set shows that it represents a valuable source of novel protein–protein
interactions with relevance to human diseases. In addition, via our preliminary analysis, we report
many novel protein interactions and pathway associations.
Molecular Systems Biology 13 March 2007; doi:10.1038/msb4100134
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Introduction
Biomolecular interactions play a critical role in the vast
majority of cellular processes. Understanding the roles and
consequences of protein interactions is fundamental for the
development of systems biology as well as the development of
novel therapeutics. Our current knowledge of biomolecular
interactions in terms of cataloging interactions and under-
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is hindered by the limitations (primarily throughput and
reproducibility) of existing technologies. Different techniques
for mapping protein interactions, such as the yeast two-hybrid
approach (Y2H) (Chien et al, 1991) and the LUMIER approach
(Barrios-Rodiles et al, 2005), are available, and address the
question of whether two proteins interact in a pairwise
fashion. We have developed a high-throughput platform
combining immunoprecipitation and high-throughput mass
spectrometry (IP-HTMS) to rapidly identify potentially novel
protein interactions for a bait protein of interest. We (Ho et al,
2002) and others (Gavin et al, 2002) previously used this
approach to map protein–protein interactions in yeast,
creating invaluable data sets for yeast biology and extrapola-
tion into mammalian biology. We have since extended this
approach to the high-throughput mapping of protein–protein
interactions in humans and reﬁned the computational proces-
sing with new methodology to assign a conﬁdence score
to each interaction. Mapping protein interactions in human
cells has its own set of challenges owing to the number of
potentially expressed genes, the number of different cell types
and the numbers of internal and external factors that impact
the cellular system. Although a complete mapping of the
human interactome is still beyond current capabilities, more
focused studies are possible. For example, application of IP-
HTMS on a smaller scale was used to study the human TNF-
alpha/NF-kappaBsignaltransductionpathway(Bouwmeester
et al, 2004). On a more global scale, the Y2H system has
recently been applied to study pairwise human interactions
(Rual et al, 2005; Stelzl et al, 2005). Here, we report the ﬁrst
large-scale application of IP-HTMS to the mapping of protein–
protein interactions in human cells using 338 human bait
proteins of signiﬁcant biomedical interest. The complete data
set is provided as a table of bait–prey pairs with associated
conﬁdence values (Supplementary Table II) and in PSI-MI
(Hermjakob et al, 2004) format from the Intact database
(www.ebi.ac.uk/intact), accession EBI-1059370.
Results and discussion
Bait selection and analytical processing
An initial set of 407 human bait proteinswas selected based on
known or implied disease associations and functional annota-
tion.Theseproteinsareimplicatedinadiversesetofbiological
processes and pathways. The most well-represented biological
process categories among the set of baits are protein
modiﬁcation, cell cycle, transcription and signal transduction,
reﬂecting the choice of bait proteins that are fundamental to
essentialcellularprocesses.Manyofthebaitsalsohaveknown
disease associations, the most well represented being breast
cancer, colon cancer, diabetes and obesity, reﬂecting our
objective to target important human diseases. Approximately
10% of the baits selected were hypothetical or poorly
annotated proteins, chosen in some cases for their homology
to proteins with disease or functional associations of interest.
The data set reported here maps interactions for 338 of the
initial set of bait proteins. A complete listing of the bait
proteins and a representative biological process from the Gene
Ontology (GO) (Ashburner et al, 2000), where available, is
provided in Supplementary Table I. (See Supplementary
Information for further details on bait selection and disease
associations.)
Analytical processing and mass spectrometry were carried
out as described in Materials and methods. In total, 1034
individualimmunoprecipitationexperimentswereresolvedby
SDS–PAGE, and proteins visualized by colloidal Coomassie
stain. Processing of the corresponding gel lanes yielded 16321
gel bands that were processed by mass spectrometry generat-
ing over 400000 MS/MS spectra that matched a peptide
sequence in the database. For over half of the baits, replicated
immunoprecipitation experiments were performed. Figure 1
shows a breakdown of the total set of experiments by type.
Prey identiﬁcation, scoring and ﬁltering
As shown in Figure 1, our data set consists of both replicated
and single-pass immunoprecipitation experiments. An addi-
tional level of redundancy arises from the fact that prey
proteins may or may not be restricted to single-gel bands in a
given lane. We, therefore, devised a data-processing pipeline
that would consolidate, organize and remove redundancy and
provide us with an accurate master list of the prey proteins
identiﬁed for each bait. Figure 2 provides an overview of this
process. Having extracted each gel band and acquired the MS/
MS data (Figure 2A), each data ﬁle was searched using the
Mascot (www.matrixscience.com) search engine. Low-quality
peptide and protein hits were then removed by applying score
threshold rules (see Materials and methods). All protein and
peptide hits corresponding to gel bands from the same bait
were combined and clustered using the algorithm outlined in
Figure 2D. The algorithm collapses proteins into clusters if
their respectivesets of matching peptides arepropersubsets of
oneanother(i.e.,ifonesetofpeptidesiscompletelyredundant
withrespecttotheother).Arepresentativeprotein(termedthe
‘anchor’ of the cluster) can then be selected from the cluster.
The anchor is selected by ranking the proteins within a cluster
by score or number of peptides and then choosing the top-
ranked protein. Ties may be broken by consideration of other
attributes, such as quantity and quality of annotation for each
protein. This process removes redundancy at the level of the
peptide matches and protein sequence; each of the anchor
proteins is guaranteed to be non-redundant with respect to its
complement of matching peptides. A small proportion (0.5%)
of the reported interactions are, however, redundant at the
level of the gene locus, that is, multiple reported prey proteins
Replicated baits ( 5 IP
experiments per bait)
Replicated baits (2 − 4 IP
experiments per bait)
Nonreplicated (1 IP
experiment per bait)
200 experiments
(200 baits)
430 experiments
(190 baits)
202 experiments
(18 baits) 202 experiments
Control experiments
Figure 1 Data processing summary. Pie chart showing categorization of all
immunoprecipitation experiments by type.
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of protein isoforms or variants and are accordingly left in the
data set.
Filtering out spurious and nonspeciﬁc proteins
In order to minimize the number of false-positive interactions,
we applied an empirical ﬁltering process to remove spurious/
contaminant proteins and nonspeciﬁcally interacting proteins
(Figure 2E). Three ﬁltering steps were applied to the
interaction network. These steps are summarized in Table I.
First was the identiﬁcation of the bait protein itself (bait–bait
interactions were removed from the network; 97% of
baits were identiﬁed at least once). Second, 207 interactions
correspondingtoinstancesofspilloverfromonegellanetothe
next were removed. Finally, we built a database of spuriously
occurring proteins and contaminants based on 202 control
(vector only) immunoprecipitation experiments. Those
proteins occurring in X2.5% of control experiments were
removed from the data set as were proteins interacting
with X5% of baits. This combined set of proteins includes
Expt1 …E x p t n
MS/ MS
acquisition
(for each
band)
…..
…..
Database search and
filtering by search score
Group all protein
and peptide hits
Prey
proteinm
protein1
Cij={…search
score, rank by
lane, best rank by
band,number
peptides….}
….
Prey
Exptn … Expt1 Baitb
…
Compute interaction
confidence score
• For each bait− prey experiment
combination, compute a scoreb a s e d
on partial least squares (PLS)
model trained on baits run in replicate
•C ompute the interaction confidence
score for a bait − prey interaction as
average of score (s) (of all observed
instances of that bait − prey) and scale
between 0 and 1
Protein and peptide clustering
•R ankp r o t einsb yscore
•D escending ranked list,a d dp rotein to
existing cluster ifp e ptide matching peptides
are proper subsets (i.e.i fc o m p l ete
redundancy) or create new cluster
• Filter out redundant clusters (retaino n l y
those clusters having at least one peptide that
is unique to thec l u s t e r )
• Select “anchor”p roteinf r o me a c hprotein
cluster
Empirical filtering
• Spurious (present in2.5% of control
experiments) and promiscuous (seen of r 
5% of baits) prey proteins removed
….
….
A B
C
D
G
E
F
Figure 2 IP-HTMS data analysis pipeline. (A–B) All bands from the lane(s) corresponding to a bait are extracted and MS/MS data acquired. (C) Data from each
MS/MSacquisitionare searchedagainstanon-redundant humanprotein sequencedatabaseusingtheMascotsearchengine. (D)Datafromallbandscorresponding to
each bait are merged and protein and peptides clustered to generate a non-redundant list of protein identiﬁcations. (E) Spurious proteins and promiscuous binding
proteinsare removed.(F)Adata tableisproduced for eachbait protein with allof the scoring information, including scores andranks byband andexperiment.Thisdata
tablecontainsalldatarequired forthe estimationofbait–prey interactionprobability. (G)Aninteractionconﬁdence scoreiscalculatedbasedupon apartial leastsquares
model trained on the replicated subset of the data.
Table I Summary of IP-HTMS interactome network ﬁltering
Filtering step Baits Unique
proteins
Interactions
Unﬁltered interaction network 407 2826 24540
Remove bait–bait interactions
a 407 2826 24211
Remove spill-over interactions
b 407 2826 24005
Remove frequent binders and
control experiment proteins
c
338 2235 6463
aThose instances where the bait protein was identiﬁed in the mass spectrometry
experiment.
bObservations of apparent spill-over from one gel lane to another; detected by
manual examination of gels and peptide/protein identiﬁcation data.
cFrequent binders deﬁned as prey proteins identiﬁed for X5% of baits; control
proteins are those ‘prey’ proteins identiﬁed in X2.5% of control experiments.
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experiments (such as human keratins) as well as proteins
observed to bind nonspeciﬁcally, and includes protein
families such as tubulins, ribosomal proteins and heat-shock
proteins.
Interaction conﬁdence scores
As many peptide and protein identiﬁcation metrics (scores,
expect values, number of peptides, peptide coverage, etc.)
can be used to assess the overall conﬁdence of a prey
identiﬁcation, we sought to combine several of these metrics
and generate an overall measure of the conﬁdence of each
prey observation (Figure 2G). Data corresponding to the set
of 18 well-replicated (X5 immunoprecipitation experiments)
baits(see Figure1) wereused as a training setto build a partial
least squares (PLS)-based regression model of prey protein
reproducibility, whereby the reproducibility was the depen-
dent variable and six predictor variables were selected to build
the model. The six predictor variables were the Mascot score
for the prey in the lane, the total number of peptides observed
for the prey in the lane, the rankof the prey protein in the lane,
a binary value indicating whether the prey is in fact the bait
protein itself, the maximum Mascot score for the prey across
all of the bands in which it was observed in the lane and the
best rank for the prey protein across all bands in the lane. The
model was trained on the replicated set of baits and then
applied to the remaining data set. Wheremultiple experiments
were performed for a bait, an averaged predicted reproduci-
bility value was calculated across all of the observations of the
given prey protein. Finally, this value was normalized to
between 0 and 1 and reported as the interaction conﬁdence
score. In a small number of cases (approximately 5% of the
reported interactions),aninteractionconﬁdence scorewasnot
calculated, because one of the predictor variables was not
available. For example, in some cases, a protein identiﬁed as
present in a given lane may not be judged as present in any of
the individual bands in that lane (peptides corresponding to
the protein may be present in different bands, none of which
scores highly enough for the protein to be considered as
present); in these cases, the predictor variable corresponding
to the best rank for the protein across all bands in the lane is
not calculated. For 18% of the interactions in the accompany-
ing data set, the interaction conﬁdence score is reported as 0.
These prey protein observations should still be interpreted as
valid as theymeet the requiredsearchengine scorethresholds.
We validated our interaction scoring metric in several ways,
demonstrating its utility as a measure of interaction con-
ﬁdence. First, using our training data set of reproduced baits,
we performed a 10-fold cross-validation of the model, and
measured the ability of our model to estimate prey reprodu-
cibility (see Supplementary Information). We found good
correlation (r¼0.66) betweenthe observed reproducibilityand
predicted reproducibility across our training set. Second, by
analyzing the subset of known interactions in the data set
(see subsequent section), we observed that the interaction
conﬁdence scores assigned to the set of known interactions
were signiﬁcantly higher than those scores assigned to
previously unknown interactions; the set of known interac-
tions has a mean interaction conﬁdence scoreof 0.43, whereas
the mean of the entire set of interaction conﬁdence scores
is 0.21, a statistically signiﬁcant difference (Wilcoxon rank
sumtest;P   0.0001).Third,weanalyzedthesetofreciprocal
interactions in the data set. In our study, no explicit effort
was made to test bait–prey interactions reciprocally (i.e., to
use the observed prey proteins as baits and see whether the
original bait proteins are identiﬁed). A small number of
interactions (21) were, however, observed reciprocally in the
data set. The interaction conﬁdence scores of these 21
reciprocally observed interactions (mean¼0.43) were signiﬁ-
cantly higher (Wilcoxon rank sum test; P   0.0001) than the
set of interactions for which a reciprocal interaction was not
observed (mean¼0.25) or indeed the whole data set
(mean¼0.21). These observations show that the interaction
conﬁdence score is a useful means of ranking the interactions
for subsequent data mining. To facilitate more in-depth
analysis of such a large data set, we focused our in-depth
interpretation of the interactions primarily on interactions
with score X0.3, corresponding to approximately one-third
(2251 interactions) of the data set. This threshold was chosen
because most interactions betweensubunits of well-character-
ized protein complexes represented in the data set (the
proteasome and eukaryotic translation initiation factors—see
below)havescores X0.3.Inaddition,for 85%ofprey proteins
with interaction score X0.3, two or more distinct peptide
sequences were identiﬁed, consistent with emerging guide-
lines for mass spectrometry-based protein identiﬁcation
(Bradshaw et al, 2006).
Computational assessment and validation
Other types of genomic information, when combined with
protein–protein interactions, can provide stronger evidence
of functional relationships between genes. Several methods
of utilizing these orthogonal genomic data to computationally
assess high-throughput protein–protein interaction data
have been proposed, such as comparison with gene expres-
sion, analysis of paralogous interactions and utilization of
functional and sub cellular localization information
(Deane et al, 2002; von Mering et al, 2002; Rual et al, 2005).
In this section, we present a computational assessment of
the IP-HTMS data set by integrating three classes of genomic
information: other human protein–protein interaction
data sources, GO annotations and gene expression microarray
data.
An important consideration when integrating other
data types is how to count the protein–protein interactions
(von Mering et al, 2002). Two paradigms for modeling
protein–protein interaction data have been proposed: the
‘spoke’ model, whereby each bait is assumed to interact with
each of its observed prey proteins, and the ‘matrix’ model,
whereby the bait and all of the preys interact with each other
(Bader and Hogue, 2002) We adopted the ‘spoke’ model for all
of our analyses (unless stated otherwise), as the ‘matrix’
model has been shown to produce higher rates of false
positives (Bader and Hogue, 2002). We recognize, however,
the limitations of the ‘spoke’ model, in particular that bait–
prey interactions identiﬁed in immunoprecipitation experi-
ments may not actually represent direct physical interactions
between the bait and prey protein.
Charting the human protein interactome
RM Ewing et al
4 Molecular Systems Biology 2007 & 2007 EMBO and Nature Publishing GroupComparison to other protein–protein interaction data
sources
Previous reports have in general found relatively little overlap
between protein–protein interaction data sets (Bader and
Hogue, 2002). For example, a recent comparison of a
comprehensive literature-curated catalog of yeast interactions
to all available high-throughput yeast interactions showed
only a 14% overlap (Reguly et al, 2006). As pointed out by the
latter authors, however, it is important to distinguish between
the absolute intersection of the two data sets (the number of
interactions in common between the data sets being com-
pared) and the intersection of ‘interaction space’ covered by
each data set. For the IP-HTMS platform, the interaction space
is the space covered by the set of bait proteins. For example, in
comparing the IP-HTMS data set to a Y2H data set, we identify
the IP-HTMS space as those Y2H interactions for which one
or more of the interactors correspond to an IP-HTMS bait.
Performing the comparisons in this way allows for realistic
estimatesofhowinteractionsarerecapitulatedacrossdifferent
studies and technology platforms.
We compared the IP-HTMS data set to three other sources
of human protein–protein interactions: a collation of
known interactions (Ramani et al, 2005), a set of interactions
predicted from lower eukaryotic interactome maps
(Lehner and Fraser, 2004) and a high-throughput Y2H study
(Rual et al, 2005). The overlap between these data sets and the
IP-HTMS data set are summarized in Table II. The overlap
between the IP-HTMS data set and these three other sources
ranges from 6 to 11%, broadly in line with observations of
the overlap between the human Y2H data set and literature-
curated interactions (2–8%) (Rual et al, 2005). By randomly
permuting the IP-HTMS bait–prey interactions and re-comput-
ing the overlaps, we conﬁrmed that the overlaps are
signiﬁcantly greater than would be expected by chance
(Po0.0001). Similar comparisons in yeast between IP-HTMS
interactions (Hoet al,2002)and literature-curatedandtandem
afﬁnity puriﬁcation (Gavin et al, 2002) and literature-curated
interactions show 20 and 30% overlaps, respectively (Reguly
et al, 2006), suggesting that a much greater proportion of the
yeast interactome has been cataloged than that the human
interactome.
The sets of interactions in common between the human IP-
HTMS interactions and each of the other three data sets are
themselves overlapping; of the total of 256 overlapping
interactions between IP-HTMS and the other three data sets,
82 are found in two or more of the overlapping sets. We also
note that interactions in common between the IP-HTMS and
other sources of human protein–protein interactions have
in general signiﬁcantly higher conﬁdence scores. The mean
conﬁdence scores for the interactions in common between IP-
HTMS and the known set, IP-HTMS and the predicted set, and
IP-HTMS and the Y2H set are 0.43, 0.43 and 0.42, respectively,
higher than expected by chance (P   0.0001; Wilcoxon rank
sum test) given the overall distribution of conﬁdence scores.
As already mentioned, it is probable that some of the bait–
prey interactions identiﬁed in IP-HTMS experiments may not
actually represent direct physical interactions between the bait
and prey protein, but instead interactions between preys. To
explore this further, we ﬁrst extended our comparisons by
considering the matrix of all possible interactions in the IP-
HTMS data set (i.e., including all possible prey–prey interac-
tions for each bait). Of the matrix of B225K possible IP-HTMS
interactions, 1678 are in common with the known set
(statistically signiﬁcantly greater than expected by chance,
Po0.0001). Although the accuracy of considering the matrix
of all interactions is expected to be lower than when only
considering bait–prey interactions (Bader and Hogue, 2002),
clearly many valid interactions remain to be discovered from
this broader approach.
Second, we compared our IP-HTMS interactions to the
literature using the Pathway Studio software (Ariadne Geno-
mics). This software enables rapid annotation of protein–
protein interactions with literature mined from various
sources. Using this approach, 145 protein–protein interactions
in our IP-HTMS data set were annotated as present in the
literature. In order to identify those IP-HTMS interactions that
represent indirect interactions between bait and prey, we
mined the literature in the following way. Bait–prey pairs from
our IP-HTMS experiments that have literaturevalidationin the
Pathway Studio database were selected. The interaction
network was then expanded by extracting all known inter-
actors from the literature that are within two edges of the prey.
Table II Comparison of IP-HTMS data set to other sources of human protein–protein interactions
Protein–protein interaction data set
Known
a Predicted
b Experimental (Y2H)
c
Interactions 31183 20469 6727
IP-HTMS baits featured in data set
d 216 123 94
Overlap with IP-HTMS space
e 2332 668 366
Intersection with IP-HTMS (number of interactions, percentage of total)
f 149, 6.4% 78, 11.4% 29, 7.9%
Randomly permuted intersection with IP-HTMS (min, mean, max)
g 7, 14.3, 25 3, 8.0, 14 0, 1.8, 7
Statistical signiﬁcance of intersection (fold-enrichment, P-value)
h B10-fold, Po0.0001 B10fold, Po0.0001 B15fold, Po0.0001
aRamani et al (2005)
bLehner and Fraser (2004)
cRual et al (2005)
dIP-HTMS baits (from total of 343) featuring in the data set.
eNumber of interactions in the data set featuring one or more IP-HTMS baits.
fNumber of shared interactions between data set and IP-HTMS.
gNumber of shared interactions between randomly permuted (1000 iterations) IP-HTMS and data set.
hFold enrichment of observed intersection over intersection expected by chance.
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expanded network such that for each bait we considered all
paths of length two where the (bait, prey) and the (bait,
interactor of prey) pairs are both in IP-HTMS, and hence, the
(prey, interactor of prey) pair can be inferred. We did the same
for paths of length three, and we enumerated all the distinct
length-one pairs from the literature that were part of the
overlapping paths. This allows us to signiﬁcantly expand the
validation of our data set using the literature by including not
just bait–prey but also prey–prey interactions. With our
additional analysis, the total number of observed interactions
that are reinforced by the literature increases to 375. This
represents a 2.6-fold increase in validation corresponding
to 6% of all of our interactions. This set of interactions is
provided in Supplementary Table IV. We have utilized this
approach in a detailed way to extend networks for individual
bait proteins. An example of this is provided in Supplementary
Figure III. Only four direct interactors of VHL from our data set
matched with the literature. Using our novel approach, we
extended the interaction surrounding VHL within two litera-
ture edges. This increased the number of proteins seen in the
VHL IP-HTMS experiment that are linked to VHL through the
literature to 13 (three-fold increase). The nine new associa-
tions are indirect but are linked through known interactors
of VHL.
Paralogous interactions
Evolutionary relationships between genes both across and
within species have been proposed as sources for discovery
and conﬁrmation of protein–protein interactions (Matthews
et al, 2001). In yeast, interactions between pairs of proteins
havebeen showntobeofhigherconﬁdence ifinteractions also
occur between paralogs of the interactors (Deane et al, 2002).
The latter authors developed the paralogous veriﬁcation
method, and showed that in yeast the method was able to
predict 40% of true interactions with a 1% false-positive rate
(Deane et al, 2002).
We explored the utility of this method for assessment of the
IP-HTMS data set by ﬁrst collating a set of 1999 groups of
human paralogs (representing 6023 human genes) from the
inparanoid database(O’Brien et al, 2005). Cross-referencingto
theIP-HTMSdatasetidentiﬁed834interactionsforwhichboth
bait and prey could be assigned one or more paralogs. Overall,
154 of these 834 interactions (18%) had one or more
paralogousinteractions.Thesetof154paralogousinteractions
are provided as Supplementary Information (Supplementary
Table III).
In many cases, these paralogous interactions are comprised
of a single bait interacting with two or more related
(paralogous) prey proteins. We also wished to test the rate at
which paralogous baits identify the same or related prey
proteins. The IP-HTMS data set provides an opportunity to do
this,becausefor16oftheIP-HTMSbaits,oneormoreparalogs
have also been used as baits. These 16 baits correspond to 157
interactions for which paralogs were assigned, and 57 of these
interactions are paralogous (36%). One caveat to analyzing
the IP-HTMS data in this way is that it is not possible to
distinguish between independent interactions of paralogous
baits with the same or related prey proteins and the scenario
whereby paralogous baits interact with each other (e.g.,
heterodimers) and that complex then identiﬁes the same set
of preys regardless of which bait is used. The set of 16
paralogous baits includes three members of the 14-3-3 protein
family, YWHAB, YWHAQ and YWHAZ. These proteins are
known to form homo- and heterodimers in vivo (Jones et al,
1995) and together contribute 35 of the 57 interactions from
paralogous baits. Nevertheless, this is a useful demonstration
ofthereproducibilityofparalogousbaits;thethree14-3-3baits
identify 117 prey proteins in total, 33 of which are identiﬁed by
more than one of the baits. Finally, we note that interactions
supported by a paralogous interaction have signiﬁcantly
higher interaction conﬁdence scores; the set of 154 paralogous
interactions have a mean score of 0.33, as compared to 0.21
across the whole data set (Wilcoxon rank sum test;
P   0.0001). As pointed out by Deane et al (2002), the
paralogous veriﬁcation method is useful only where paralogs
can be identiﬁed. This is only possible for a relatively small
fraction (834 outof 6463 interactions) of theIP-HTMS dataset.
Nevertheless, we believe that this ﬁrst preliminary analysis of
paralogous interactions in the human interactome illustrates
thepotentialforfurtherin-depthstudiesasourabilitytoassign
paralogs improves and our knowledge of the human inter-
actome increases.
Biological process and pathway enrichment
To gain an overview of the classes of proteins identiﬁed as
preys for each of the baits, we used the GO (slim subsets) to
analyze biological process and cellular component category
representation. In both cases, the distribution of prey proteins
amongthe categories issimilar tothedistribution of categories
among bait proteins; the most well-represented bait biological
process protein categories—protein modiﬁcation, protein
biosynthesis, cell cycle, transcription and signal transduction,
are also the most well-represented prey protein categories.
We used the GO annotation to analyze the degree to which
bait and prey interactors share the same or related GO
categories. For high-throughput yeast data, the fractions of
interactions for which both interactors have the same high-
level biological process or cellular component categories have
been estimated at 20 and 27%, respectively (Reguly et al,
2006).ForourhumanIP-HTMSdata,thesefractionsare12and
20%, respectively. To illustrate these associations in more
detail, we generated bait–prey coincidence maps (Figure 3) in
which the association between each combination of bait and
prey GO categories is tested using a contingency table and
statistical test (Fisher exact test). Each combination of bait GO
category, i, and prey GO category j, is represented as a cell in
the matrix, and the color of the cell represents the statistical
signiﬁcanceoftheassociationbetweenbaitcategoryiandprey
category j. We also implemented a permutation procedure to
characterize the distribution of P-values derived from random
associations (see Materials and methods). The permutation-
based P-value for each bait–prey category combination was
calculated as the fraction of times the Fisher exact test P-value
was less than the observed ‘real’ P-value. On this basis, the
bait–prey category combinations with P-values less than or
equal to 0.0001 are all judged to be highly signiﬁcant; smaller
P-values for each of these category combinations were not
Charting the human protein interactome
RM Ewing et al
6 Molecular Systems Biology 2007 & 2007 EMBO and Nature Publishing Groupobserved across 1000 independent random permutations of
the bait–prey categories.
This analysis revealed a signiﬁcant tendency of baits to
interact with prey proteins implicated in the same or similar
biological process (Figure 3A and B). For example, the most
signiﬁcant bait–prey biological process category combinations
were protein biosynthesis/protein biosynthesis (P¼1.7e 09)
and catabolism/catabolism (P¼2.3e 08). These correspond
to two highly connected clusters of interacting proteins
representing known macromolecular complexes—translation
initiation and elongation factors and the proteasome (both
discussed in more detail below). Similar results were obtained
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except that signiﬁcant off-diagonal associations were also
seen. Most notably, a signiﬁcant enrichment is seen between
baits assigned to the plasma membrane baits and endoplasmic
reticulum/Golgi preys. This enrichment is largely due to two
members of the tumor necrosis factor receptor super-family
baits (TNFRSF14 and TNFRSF5) interacting with several
endoplasmic reticulum prey proteins. These two baits interact
with an overlapping set of endoplasmic reticulum-associated
proteins including several components of the microsomal
signal peptidase complex and endoplasmic reticulum-asso-
ciated protein disulﬁde isomerase family members. Although
it is not clear what the actual biological explanation might be,
we believe that these are not spurious observations as this
group of prey proteins is also identiﬁed using the TRAF6 bait
(TNF receptor-associated factor), a known mediator of
signaling from TNFRSF5.
Integrated analysis of the IP-HTMS and GO categories also
facilitated discovery of some very speciﬁc but potentially
biomedically important interactions. Relatively few proteins
in the IP-HTMS data set are assigned to the peroxisome
(17 interactions involve a peroxosomal bait or prey). Of these
interactions, a single interaction was observed between a
peroxisomal bait and a peroxisomal prey: PHYH (phytanoyl-
CoA 2-hydroxylase) bait identiﬁed ABCD3 (ATP-binding
cassette, subfamily D) as a prey. Defects in the functioning
of both PHYH and ABCD3 are implicated in Zellweger’s
syndrome and other peroxisomal biogenesis disorders, a set of
potentially severe (fatal) inherited diseases (Moser, 1999;
Steinberg et al, 2006). In addition, several studies have shown
interactions between ABCD proteins and peroxisomal biogen-
esis factors (PEX proteins) and between PHYH and PEX
proteins (Liu et al, 1999; Gloeckner et al, 2000). To our
knowledge, our observation is the ﬁrst indication of a protein–
protein interaction between PHYH and ABDC3.
Cross-referencing gene expression information
Increased similarity of gene expression proﬁles for genes
encoding interacting proteins has been demonstrated in
yeast (Ge et al, 2001). Preliminary evidence that this may also
be the case in higher eukaryotes has been reported for
Caenorhabditis elegans (Li et al, 2004) and in humans
(Hahn et al, 2005; Rual et al, 2005). In the latter case,
enrichmentforhighergeneexpressioncorrelationwasseenfor
both literature-derived interactions and, albeit at a lower level,
for the experimentally derived data set (Rual et al, 2005).
One of the principal issues in attempting to measure whether
a relationship exists between gene expression and protein
interactiondatasetsistheincompletenessandarbitrarynature
of selecting appropriate human gene expression
data. Rather than select individual data sets over which
co expression could be measured, we made use of a
compendium of co-expression measurements generated from
3924 microarrays from 60 different human studies (Lee et al,
2004). Co-expression links in this study are deﬁned as positive
or negative based upon their position within the extremes
of the distributions of correlation for each study (Lee et al,
2004). Figure 4 shows the respective fractions of positive and
negative co-expression links for several sets of interaction
data. For the complete set of approximately 9 million co-
expression measurements, a slight bias towards positive
measurements was observed (Lee et al, 2004). We ﬁrst
conﬁrmed that the ratio of positive to negative co-expression
counts for measurements within the IP-HTMS space
(i.e., where one or more of the pair of coexpressed genes
corresponded to an IP-HTMS bait) was broadly similar to the
bias observed in the complete data set (respective positive
to negative ratios are 1.25 and 1.32). We then observed that
elevated positive to negative ratios were observed for both the
IP-HTMS data set and the human Y2H data set (Rual et al,
2005) and for the set of known interactions (Ramani et al,
2005), suggesting that human gene pairs encoding interacting
proteins are also more likely to be coexpressed.
The magnitudes of the positive to negative ratios for the
IP-HTMS and Y2H data sets are similar (2.33 and 2.50,
respectively), whereas the ratio for the known set is
signiﬁcantly higher (4.75). We also conﬁrmed that the ratio
of positive to negative co-expression counts for the IP-HTMS
data set is statistically signiﬁcantly higher (Po1e 6, 1 million
iterations)thanexpectedbychancebyrandomlysamplingsets
(1028 co-expression pairs—the same size as the observed
overlap) of co-expression pairs from the IP-HTMS space
(mean ratio¼1.32, maximum ratio¼1.68).
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Figure 4 Comparison of interaction data sets to gene co-expression data. Red
and green fractions of each bar correspond respectively to the proportions of
positive and negative co-expression correlations for each data set. The numbers
above each column represent the numbers of co-expression measurements
overlapping the respective data set, and the numbers in parentheses represent
the ratio of positive co-expression correlations to negative co-expression
correlations. (1) The complete set of co-expression correlation measurements
(Lee et al, 2004). (2) The set of co-expression gene pairs mapping to one
or more IP-HTMS baits. (3) The set of IP-HTMS bait–prey pairs for which a
co-expression measurement is available. (4) The set of Y2H (Rual et al, 2005)
interactions for which a co-expression measurement is available. (5) The set of
known(Ramanietal,2005)interactionsforwhichaco-expressionmeasurement
is available.
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co-expression data for further in-depth discovery of functional
relationships between genes. The LYAR (Ly-1 antibody
reactive) protein was originally isolated from a mouse
T-cell leukemia cell line and shown to encode a predominantly
nucleolar-localized protein (Su et al, 1993). As an IP-HTMS
bait, LYAR identiﬁed 79 prey proteins, and of these, 32
were also found as coexpressed genes in the co-expression
database (Lee et al, 2004). Twelve of these co-expression links
are classed as stringent (co-expression observed across
three or more gene expression studies) (Lee et al, 2004), and
are represented in Figure 5. All of the 12 co-expressors/
interactors are positively coexpressed and are nonrandomly
distributed within the distribution of all co-expression
P-values for LYAR(see Figure 5). Indeed, twoLYAR interactors,
BRIX and DKC1, are the two most highly coexpressed genes
for LYAR across the complete co-expression database. All of
the 12 (except one hypothetical protein) coexpressing/
interacting proteins have been documented as nucleolar
proteins (see Figure 5). Overall, these coherent co-expres-
sion/interaction patterns are not uncommon in our data set;
32 IP-HTMS baits show stringent co-expression with two or
more of their prey proteins.
Biological interpretation of the interaction network
Global visualization of the IP-HTMS data set
ToaidinterpretationoftheIP-HTMSdataset,wevisualizedthe
interactionnetworkintwoways.First,togloballyvisualizethe
data set, we developed the bait–bait connectivity map (Figure
6A and B). This visualization reduces the complexity and
highlights salient features of the data set by representing only
bait proteins and the degree to which theyshare prey proteins.
Second, we visualized selected fragments of the complete
(baits and preys) interaction map (Figure 6C–F). The
biological signiﬁcance of two of these maps (the NIMA family
kinase, Nek6 interactions and translation initiation and
elongation) is discussed in more detail in subsequent sections.
Several features of the data set are clear from the bait–bait
map in Figure 6A. First, as shown in the lower part of the
graph, many baits (approximately 30%) are poorly connected;
that is, the set of prey proteins identiﬁed is quite distinct from
the set of preys identiﬁed for any other bait. This is a
consequence of both the empirical ﬁltering that was applied to
the data set (whereby frequent prey proteins and proteins
observedinthecontrolexperimentsthatwouldotherwisetend
to join all baits to one another were removed) and the fact that
the baits selected for the study are proteins implicated in a
wide variety of diseases, processes, pathways and complexes.
Second, where data from multiple baits from the same
complex and process are available, those baits are well
connected to one another. Several of these interconnected sets
of baits are indicated in Figure 6A and B (cross-referenced by
roman numerals). Forexample, the ﬁve baits corresponding to
the proteasome included in the study form a largely distinct,
well-connectednetworkasshowninFigure6AandB,paneliv.
The complete interaction map for these ﬁve baits is shown in
Figure 6C. The identiﬁed prey proteins include many core and
regulatory components of the proteasome. Other well inter-
connected sets of baits include spliceosome complex compo-
nents (Figure 6A and B, panel i), chromatin remodeling
components (Figure 6A and B, panel ii), the translation and
elongation factor baits (Figure 6A and B, panel iii), the 14-3-3
protein baits (Figure 6A and B, panel v) and sumoylation
pathway components (Figure 6A and B, panel vi). For several
of thesewell-connected bait clusters, we havealsorepresented
the corresponding complete interaction maps (Figure 6A and
B, panel iii corresponds to Figure 6F, Figure 6A and B, panel iv
corresponds to Figure 6C, and Figure 6A and B, panel vi
corresponds to Figure 6D). Each of the 14-3-3 baits (Figure 6A
and B, panel v) identiﬁed a largely overlapping set of preys, an
anticipated result given that these proteins form homo- and
heterodimers in vivo (Jones et al, 1995). A subset of the
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were previously reported and analyzed in-depth (Jin et al,
2004)(approximately60%ofthe14-3-3preyproteinsreported
in the current study were reported by Jin et al (2004)). In
addition, these authors analyzed the domain proﬁles of the
identiﬁed prey proteins and validated the interaction with the
RhoGTPaseactivator, AKAP13, aninteraction identiﬁedin our
studywithtwo(YWHABandYWHAG)ofthefour14-3-3baits.
NIMA family kinases and the mitotic cascade
TheNIMA(neverinmitosisgenea)wasoriginallydescribedin
Aspergillusnidulansasa key regulatorof entry intothemitotic
cycle. Hence, families of NIMA-related kinases (Nek) have
since been found to be widely distributed in eukaryotes with a
conserved role in regulation of mitosis (Lu and Hunter, 1995;
O’Connell et al, 2003). In humans, 11 members of the Nek
family have been described. Nek6 was previously shown
to be essential for mitotic progression in human cells, and
was suggested to be particularly important for the metaphase–
anaphase transition (Yin et al, 2003) and chromatin condensa-
tion (Hashimoto et al, 2002). Expression analysis also
suggested an association of Nek family members with
chromosome instability and cancer (Bowers and Boylan,
2004; Hayward and Fry, 2005). Nek6 bait was used in
three IP-HTMS experiments, and 42 prey proteins were
identiﬁed (see the interaction map in Figure 6E). Of particular
interest in this set of Nek6 interacting proteins are those
Number of
preys
Nucleobase, nucleoside,
Nucleotide and nucleic acid
metabolism
0.3 − 0.4
1 − 5
6 − 50
51 − 100 0.2 − 0.3
<0.2
>0.5
Preys in
common
>100
Response to biotic stimulus
DNA metabolism
Signal transduction
Protein modification
Cell − cell signaling
Cell − cycle
Protein biosynthesis
Unclassified
Transport
Process/disease classification
Breast cancer
RGS2
EIF4A1
EIF4A2
EIF3S10
CNTF
EIF4EBP1
YWHAG
YWHAQ
YWHAZ
YWHAB
PSMD10
PSMC4
PSMD13
P44S10
HTR1E
FLJ11848
RIOK3
PASK
UBE2I SAE1
CD2BP2
SNRPB
HPRP8BP
SNURF
REC14
GNAS
DNASE2
RUVBL2
RUVBL1 BCAS1
SNCG
ENSA
(i)
(iii)
(ii)
(v)
(iv)
(vi)
(iii)
(v)
(vi)
(iv)
(i) (ii) A
B
Figure6 Globalandfocusedviewsofhumaninteraction map.(A)Completebait–baitconnectivity mapfor323humanbaitproteins.Baitsarerepresentedasnodesin
the graph. The size of the node represents the number of prey proteins identiﬁed for the bait. The thickness of edges between nodes represents the proportion of preys
in common between the baits. Nodes are colored according to a combined disease and biological process classiﬁcation, and selected classes indicated in the legend.
(B) Focused views of selected bait–bait subnetworks (cross-referenced by roman numerals to panel A). (C–F) Complete interaction networks (representing both baits
and preys) for selected groups of baits. Nodes are colored according to cellular component or biological process as indicated on each ﬁgure. Baits are shown as large,
labeled oval shapes, preys as small, labeled oval shapes. Arrow direction indicates a bait–prey relationship and line thickness indicates the interaction conﬁdence score
(see legend in panel C). Preys are grouped according to the baits with which they were identiﬁed (except panel E where they are grouped according to interaction
conﬁdence score).(C)Proteasome baits(correspondstobait–bait clusterB(paneliv)).(D)Sumoylationpathway (correspondstobait-baitclusterB(panelvi)).(E)Nek6.
(F) Translation initiation and elongation (corresponds to bait–bait cluster B (panel iii)).
Charting the human protein interactome
RM Ewing et al
10 Molecular Systems Biology 2007 & 2007 EMBO and Nature Publishing Groupwith roles in the mitotic cascade, chromosomal remodeling
and regulation of the cell cycle. Both Nek7 and Nek9 were
identiﬁed as interacting proteins with high conﬁdence (Nek9
is the highest scoring prey for Nek6). In addition, these two
prey proteins are quite speciﬁc; Nek7 was only identiﬁed in
the Nek6 experiments, whereas Nek9 was identiﬁed with one
other bait, GABARAPL2. Previous work showed that
Nek9 activates Nek6 during mitosis and possibly regulates
Nek7 as well (Belham et al, 2003). In addition, previous
immunoprecipitation experiments showed that Nek6 binds
Nek9 (Nercc1) (Roig et al, 2002). The Nek6 experiments also
identiﬁed key components of the cohesin and condensin
complexes (SMC1L1, SMC2L1, MTB, CNAP1, CSPG6 and
MCM7) required for condensation, segregation and structural
maintenance of chromosomes during mitosis in addition to
several microtubule-associated proteins (EML2, EML3 and
EML4). Although not well understood, the latter ‘echinoderm
microtubule-associated’ proteins are thought to play a role in
regulation of microtubule dynamics during mitosis (Eichen-
muller et al, 2002). In our study, these proteins were only
identiﬁed with the Nek6 bait. Nek6 also identiﬁed several
known cell-cycle regulators (WEE1, CDC37 and RBL1),
although we note that the retinoblastoma-like protein,
RBL1, was previously shown to bind MCM7 (Sterner et al,
1998), suggesting that Nek6 may not bind directly to both
of these proteins. Besides the strong association of Nek6
with the mitotic cycle, Nek6 interacts with several
proteins involved in nuclear import/export (TNPO3, IPO4,
XPO5 and NUP93). Interestingly, NIMA kinase appears to be
required for conformational changes to the nuclear pore
complex during mitosis in Aspergillus (De Souza et al, 2004).
Furthermore, a direct interaction between the nucleoporin
93kDa (NUP93) and NIMA kinase has been shown
and suggested to be required for nuclear accumulation of
mitotic regulators (De Souza et al, 2003). Our data
therefore suggest that the Nek family members are also
required for nuclear pore complex regulation in higher
eukaryotes.
Translation initiation and elongation factors
The molecular mechanisms underlying protein synthesis in
eukaryotic organisms are complex and only partially
understood (Kapp and Lorsch, 2004). The eukaryotic
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the assembly of the ribosome at the initiation codon,
elongation—the positioning of aminoacyl tRNAs into the
acceptor site, termination—occurring when a stop codon is
encountered, and ﬁnally the recycling of the ribosomal
machinery. As part of our protein interaction mapping,
we selected six eukaryotic translation initiation factor (EIF)
proteins as baits (EIF2B1, EIF3S10, EIF4A1, EIF4A2, EIF4EBP1
and GC20). A total of 222 interactions were identiﬁed for
these six baits, primarily with GC20 (162 interactions) and
EIF4A2 (42 interactions). Seventy-ﬁve interactions have an
interactionconﬁdencescoregreaterthan0.3,and60%ofthese
interactions arewith othereukaryotic initiation factor proteins
or components of the translational machinery. We focus
our discussion here on this subset of the interactions. Our
results recapitulate many of the known complexes and steps
involved in translation initiation and demonstrate both the
speciﬁcity and sensitivity of the IP-HTMS approach. Figure 6F
shows a bait–prey interaction map for the six initiation
factor baits. All of the interactions are shown except for
GC20 and EIF4A2 baits, for which only selected prey proteins
are shown.
The ﬁrst step of translation initiation is the formation of
a ternary complex between GTP, Met-tRNA and EIF2 and
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ribosomal complex to form the 43S preinitiation complex
(Pestova et al, 2001). We observed several complexes that
participate in this process. GC20 is a homolog of the
yeast SUI1/EIF1 protein, known to be required for binding
of the GTP/Met-tRNA/EIF2 complex to the 40S ribosome
(Majumdar et al, 2003). In our experiments, the GC20 bait
identiﬁed several components of the EIF2 complex.
EIF3 is also required for generation of a stable 40S pre-
initiation complex. Our experiments with GC20 and EIF3S10
identiﬁed many of the EIF3 components (EIF1 (GC20 homo-
log) has previously been shown to interact with EIF3 (Fletcher
et al, 1999)).
The EIF3S10 experiments demonstrate the speciﬁcity and
sensitivity of the IP-HTMS approach; this bait identiﬁed eight
prey proteins, seven of which are documented EIF3 subunits.
Interestingly, the remaining prey protein, GA17, dendritic cell
protein, contains a Proteasome/COP9/Initiation factor (PCI)
domain, a domain of unknown function but which is seen in
components of multi-subunit complexes, such as the protea-
some, COP9 and EIF3. Our results support recent work
suggesting that GA17 is an additional subunit of EIF3
(Unbehaun et al, 2004).
ThenextstepintheprocessismRNAbindingtoformthe43S
pre-initiation complex. EIF4H is known to interact with EIF4A
as part of this process and was observed in our experiments
(Richter et al, 1999). Both EIF4A and EIF4H were observed in
the raw data for the GC20 immunoprecipitation experiments,
althoughEIF4Awasremovedbasedonourﬁlteringcriteriaand
EIF4H assigned a low interaction conﬁdence score.
Eukaryotic messenger RNAs contain a modiﬁed guanosine,
termed a cap, at their 50 ends. For translation to proceed,
binding of an initiation factor, EIF4E, to the cap structure is
required (Richter and Sonenberg, 2005). EIF4B binds near the
50-terminal cap of mRNA in the presence of EIF4Fand ATP. EIF
4G1, 4G2, 4E and 4A are known components of the EIF4F
multi-subunit complex, all of which were observed in our
experiments with the EIF4 baits. EIF4E and protein translation
as a whole are regulated in part by the EIF4E binding protein,
EIF4EBP1 (Haghighat et al, 1995). In our experiments, the
EIF4EBP1 bait identiﬁed a single prey protein, EIF4E. The
PDCD4 (programmed cell death 4) protein was identiﬁed as a
prey in both EIF4A1 and EIF4A2 experiments. The PDCD4
gene product has been reported to be a tumor and transforma-
tion suppressor and proposed as a target for cancer therapy
(Lankat-Buttgereit and Goke, 2003). PDCD4 has also been
shown to inhibit translation through its binding to EIF4A and
EIF4G (Yang et al, 2004; Zakowicz et al, 2005). Our results
support these reports and suggest that PDCD4 interacts very
speciﬁcally with the translation machinery; PDCD4 was seen
only with the EIF4A1 and EIF4A2 baits.
Finally, EIF2B functions to recycle the EIF2–GDP complex
and recreate EIF2–GTP, which is then ready for a subsequent
round of initiation. Immunoprecipitation using EIF2B1 identi-
ﬁed six prey proteins, two of which (EIF2B3 and EIF2B5) are
documented EIF2B components.
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Figure 6 Continued.
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occurringduringthecomplexprocessofeukaryotictranslation
initiation. With six bait proteins covering the major processes
of initiation, we are able to identify many relevant interacting
proteins and provide a rich data set for further discovery.
Future prospects
Thisstudypresentstheﬁrsthigh-throughput analysisofnative
protein complexes by IP-HTMS in a human cell line. As
illustrated in this report, our data set provides for both
recapitulation of known complexes and discovery of new
interactions and complexes. Although our data set maps
interactions for proteins implicated in a broad range of
pathways and processes, we anticipate that future, focused
applications of the IP-HTMS approach will begin to probe in
greater depth the impact of disease states and drug treatments
on human protein–protein interactions.
Materials and methods
Cloning of the bait cDNAs and construction of
entry clones
Full-length cDNAs encoding the genes for the respective protein baits
wereeitherpurchasedfromInvitrogen(www.invitrogen.com)andthe
Kazusa project (www.kazusa.or.jp) or cloned in-house. Established
polymerase chain reaction (PCR) methodologies were used to amplify
the bait cDNAs from the corresponding parent plasmid DNAs. The
oligonucleotide primers used for PCR (four required for each unique
bait gene; two 50-terminal primers, with Kozak code or not, and two
30-terminalprimers, withor withouta stop codon)were designedto be
complementary to the 50 and 30 ends of the bait coding region and to
introduce an additional nucleotide sequence (29bp), corresponding to
Gateway attB recombination sites (Invitrogen), onto the ends of the
PCRproduct. To createGatewayentry vectors, a portion ofthe puriﬁed
PCR reaction product was added to the BP Reaction mixture, which
contains a donor vector (encoding attP sites) and the BP CLONASE mix
of recombination proteins. The recombination results in the oriented
integration of the attB ﬂanked PCR product into the attP sites of the
donor vector, generating the Entry Clone inwhich the bait gene coding
region is now ﬂanked by attL sites (required for the LR Reaction, see
below). A portion of the BP Reaction was used to transform competent
Escherichia coli DH5a cells and the Entry Clone plasmid DNA was
puriﬁed fromselected transformants(antibiotic selection)using routine
plasmid miniprep protocols (Sigma-Aldrich, www.sigmaaldrich.com).
The integrity of each Entry Clone was veriﬁed by PCR ampliﬁcation
using gene-speciﬁc primers and DNA sequencing.
Construction of destination vectors
Two Destination Vectors, DV1 and DV2, were constructed based on a
vector backbone using standard recombinant DNA methodologies.
The Entry Clone and Destination Vector weresubjectedto the GATEWAY
LR Reaction, which contains the LR CLONASE mix of recombination
proteins. The LR Reaction results in the directional transfer of the bait
gene coding region, ﬂanked by the attL sites in the Entry Clone, to the
Destination Vector (DV1 or DV2) through recombination with the attR
ﬂanked GATERC, generating the Expression Clone. A portion of the LR
Reaction was used to transform competent DH5a cells and the
Expression Clone plasmids were puriﬁed from selected transformants
(antibiotic selection) using routine plasmid miniprep protocols.
Following conﬁrmation by PCR with gene-speciﬁc primers, milligram
quantities of puriﬁed Expression Clones were prepared by standard
protocols (Maxiprep; Sigma-Aldrich).
Cell culture
Anchorage-dependent human embryonic kidney 293 (HEK293) cells
were maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
containing 10% fetal bovine serum and supplemented with 2mM
L-glutamine and 0.1mM nonessential amino acids. Cells were grown
in 10-cm-diameter or 24.5 24.5cm
2 tissue culture plates at 371Ci na
5% CO2 atmosphere. Cells were routinely tested for mycoplasma
presence. A detailed protocol for the maintenance and passaging of
cells is provided in Supplementary Information.
Transient transfection
A seed culture of HEK293 cells (at 70–80% conﬂuence) was split and
plated with fresh media the day before transfection and then grown to
30–40% conﬂuency. Before performing transfection, cell plates were
individually veriﬁedbymicroscopy.In particular, weveriﬁedthat cells
were healthy—no large vacuoles, no long extensions, not rounded up,
no contaminationwaspresent (mould, yeastor bacteria) and less than
5% dead cells. We also conﬁrmed that the plates were approximately
40% conﬂuent. Any plates that did not meet the above criteria were
discarded. Typically, approximately 1 10
7 cells were transiently
transfected by adding 5mg of DNA construct in the form of a calcium
phosphate/DNAcoprecipitationprotocol.Brieﬂy,asolutionofcalcium
chloride and maxiprep Expression Clone plasmid DNA was diluted
with an inorganic phosphate-containing buffer. The mixture was
overlaid on the cells following a brief period to allow the calcium
phosphate/DNA precipitate to develop. Cells were incubated at 371C
with the calcium phosphate DNA mixture for 12–16h, the culture
medium was replenished and the cells was cultured a further 24h to
B90% conﬂuence before harvest. A similar procedure was used to
culture HEK293 cells that were transiently transfected with the
Destination Vector (no bait gene) in order to provide a negative-
control sample. A detailed protocol for the transfection is provided in
Supplementary Information.
Cell harvest and extract preparation
Allmethodsusedduringthe harvest procedurewere performedat 41C.
Following the culture period described above (for each experimental
and control culture), the media were removed from the plates by
aspiration and the adherent HEK293 cells were washed thoroughly
with Tris-buffered saline. Cells were then overlaid with a predeter-
minedvolumeofdetergent-containinglysisbuffer(supplementedwith
a cocktail of protease inhibitors) and then scraped to concurrently
dislodgeandlysethecells.Typically,cellswerelysedbytheadditionof
(1ml) of lysis buffer (20mM Tris–HCl (pH 7.5), 150mM NaCl, 1mM
EDTA, 1% NP-40, 0.5% sodium deoxycholate, 10mg/ml aprotinin,
0.2mM AEBSF (Calbiochem)). The cell lysate was collected and then
clariﬁed by preparative centrifugation for 30min at 20000g to yield a
crude extract. In all cases, portions of the soluble and insoluble
fractions from the centrifugation were separated by SDS–PAGE and
immunoblotted with an anti-FLAG
s (M2) monoclonal antibody (see
below) to verify the bait’s presence in the soluble extract fraction.
Immunoprecipitation of bait and bait-speciﬁc
interacting proteins
The Flag-tagged bait proteins and their interacting partners were
isolated from cell extracts by immunoprecipitation using M2-Agarose
resin (Sigma-Aldrich). The M2-Agarose comprises the monoclonal
anti-Flag M2 antibody immobilized onto an agarose resin and reacts
speciﬁcally with fusion proteins possessing the Flag epitope at the
N- or C-terminus. Brieﬂy, the crude lysate were ﬁrst incubated with
5mg of agarose beads for 60min at 41C to remove nonspeciﬁc binders.
Thesupernatantwasthensubjectedtoimmunoprecipitationbyadding
5mg of anti-Flag monoclonal antibody covalently attached to cross-
linked agarose beads (M2, Sigma). The mixture was gently agitated by
inversion for 60min at 41C. Immunocomplexes associated with the
insoluble fraction were recovered by centrifugation (1000g for 2min)
and washed by three cycles of resuspension in lysis buffer followed by
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from the beads by resuspension in 250ml of 50mM ammonium
bicarbonate (prepared just before to use) containing 400mM Flag
peptide. Following a 30min incubation, beads were removed by
centrifugation and the supernatant containing Flag peptide as well as
the eluted proteins was lyophilized.
Gel-based protein analysis
The dried immunopuriﬁed proteins were solubilized in a minimal
volume of protein-loading buffer and subjected to SDS–PAGE. The
immunopuriﬁed proteins were then separated by gel electrophoresis
and detected by colloidal Coomassie staining. All gels were subjected
toavisual appraisal before further processing;gel lanesthat contained
anomalies such as signiﬁcant background across the entire lane or a
large number of protein bands arising from nonspeciﬁc protein
precipitation were rejected (approximately 40% of the gels were
rejected based on these criteria). Band excision was automatically
performed by a robotic system developed in-house and gel bands
automatically transferred to a 96-well plate. Post-excision steps were
carried out using commercially available automated robotic work-
stations (ProGest, Genomic Solutions). The proteins contained in the
excised gel bands were treated with dithiothreitol (DTT) and the free
sulfhydryl groups were alkylated using iodoacetamide. Proteins were
then digested with trypsin and the resulting peptides were extracted
from the gel slice using a series of wash steps. The extracted peptides
were concentrated and analyzed directly by mass spectrometry.
Mass spectrometry
LC-ESI-MS/MS identiﬁcation of proteins was performed as described
previously (Figeys et al, 2001) using an automated network of mass
spectrometers. Tryptic peptides recovered from individual gel bands
were separated by reverse-phase chromatography on C18 resin and
directlyinjectedintoamassspectrometer.Iontrapmassspectrometers
(LCQ Deca, Thermo Finnigan), operated in a data-dependent mode,
which produces tandem MS spectra of all peptide species present
above a programmed threshold, were used for these experiments.
Note: Additional detailed experimental protocols for cell trans-
fection and passaging of cells are provided in Supplementary
Information.
Data analysis
Data management
Laboratory data were managed using an in-house developed LIMS
system that tracks all steps of immunoprecipitation, gel band excision
as well as mass spectrometryacquisition names, annotated SDS–PAGE
images and QC data. Mass spectrometry acquisition ﬁles were stored
on a centralized network ﬁle system and processed using an
automated analysis pipeline, including a cluster of Mascot nodes for
peptide and protein identiﬁcation.
Peptide and protein identiﬁcation
All spectra were analyzed using Mascot version 1.9 (Matrix Sciences,
www.matrixscience.com) searches against a non-redundant human
protein sequence database (122989 entries), constructed from all
major sources of human protein sequences (GenBank, TrEMBL,
SwissProt, IPI and Ensembl). Mascot was run in MS/MS Ion search
mode with the following parameter settings: ﬁxed modiﬁcation
(carbamidomethyl on cysteine), variable modiﬁcation (oxidation on
methionine), peptide mass tolerance 2Da, fragment mass tolerance
0.4Da, maximum missed cleavages two and enzyme trypsin. Peptide
and protein identiﬁcations were included for further analysis accord-
ing to the following criteria: for single peptide hit proteins, Mascot
ionscore X40; for proteins with multiple peptide hits, each Mascot
peptide ionscore X20. (The average Mascot recommended (Po0.05)
ionscore for our data is B40.) Further assessment of the peptide and
protein identiﬁcation false-positive rates was made by searching a
subset (500 gel bands; B3% of the data) against a randomized (each
entry randomly shufﬂed) sequence database. Using Mascot ionscore
thresholds as above, we estimate a protein false-positive rate of
o7.5%.Mascotresultﬁleswereparsed,proteinsclusteredandalldata
stored in a relational database. An in-house protein sequence index
and annotation system was used to both provide the non-redundant
sequence search database and to interpret and analyze the resulting
proteinhits.Spotﬁre(www.spotﬁre.com),cytoscape(www.cytoscape.
org) softwares and Pathway Studio (Ariadne Genomics) were used
extensively for data analysis and interaction map visualization
respectively. The PLS regression analysis and generation of interaction
conﬁdence score was implemented in custom code using Python
(www.python.org).
Comparisons to other data sets
Comparisons were made in general by cross-referencing NCBI Gene
Ids where possible, or ofﬁcial HUGO gene symbols. For comparison to
other protein interaction data sets, computation of statistical sig-
niﬁcance was carried out by repeatedly randomizing (1000 iterations)
the IP-HTMS bait–prey associations and recalculating the interactions
in common between the set of randomized interactions and the data
set being compared. Minimum, mean and maximum counts of the
interactions in common were then calculated from the 1000 trials.
Cross-referencing to the inparanoid database (O’Brien et al, 2005) was
performedbydownloadingallorthologouspairsforHomosapiensand
then forming paralogous groups of human genes in a simple, single-
link fashion. Integration of the gene co-expression compendium (Lee
et al, 2004) was performed by cross-referencing gene symbols.
GO analysis
GO-Slim versions of the Gene Ontology (www.geneontology.org/
GO.slims.shtml) were used to map baits and preys to biological
processes and cellular component categories (courtesy of Suparna
Mundodi and Amelia Ireland, and MGI, www.spatial.maine.edu/
~mdolan/MGI_GO_Slim.html),respectively.Inaddition,certainbaits
were ‘up-propagated’ to parent categories where representation was
low. Eighty percent of proteins in the interaction network were
assigned biological process categories and 77% cellular component
categories (55% of interactions were assigned biological process
categories for both bait and prey, 33% of interactions were assigned
cellular component categories for both bait and prey). Each combina-
tion of bait GO category and prey GO category was tested for
association by constructing a 2 2 contingency table and using the
Fisher exact test. Distributions of P-values from randomly permuted
bait–prey categories were characterized as follows. Random permuta-
tion of bait–prey category associations (1000 trials) were performed,
contingency tables for each bait–prey category combination con-
structed and the Fisher exact test P-value calculated. These distribu-
tions of 1000 P-values for each bait–prey category combination were
then used to calculate the frequency with which a P-value less than or
equal to the observed non-random P-value is seen by chance.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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